Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies and Antibody Drug Conjugates

Arumugam Muruganandam's Biography



Arumugam Muruganandam, Mananging Director & Chief Scientific Officer, Affigenix Biosolutions Pvt Ltd

Dr.Arumugam Muruganandam, PhD., MBA. Affigenix: Managing Director and Chief Scientific Officer at Affigenix Biosolutions Pvt. Ltd., Bangalore, India. Protein Biochemist and cell biologist with 24+ years’ experience in academic (USA & Canada), government (NRC, Canada) and corporate (Dyax, USA and Biocon, India) research environments, with proven track record of successfully leading and managing development of biotherapeutics for treating or diagnosing different diseases. Experience in immunoanalysis, immunogenicity, PK, and CMC assays applied to drug development with excellent understanding of large molecules/biologics/biosimilar drug development. Core strengths include bioanalytical and biomarker assay development, preclinical and clinical PKPD, phage display and developing 3D in vitro blood brain barrier models. He has several publications and patents in the area of biologics to his credit. Muruganandam is a Global Bioanalysis Consortium (GBC) Member in two of the large molecule harmonization teams focusing on ligand binding (PK) assays.

Arumugam Muruganandam Image

Best Practices in Developing Bioanalytical Assays for Assessment of Antibody-Drug Conjugates

Friday, 30 September 2016 at 11:45

Add to Calendar ▼2016-09-30 11:45:002016-09-30 12:45:00Europe/LondonBest Practices in Developing Bioanalytical Assays for Assessment of Antibody-Drug ConjugatesAntibodies and Antibody Drug Conjugates in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonAntibodies and Antibody Drug ConjugatesAntibodies and Antibody Drug Conjugates in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com